TherapeuticsMD® Announces Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St kicks off September under pressure as higher yields, oil prices weigh
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
TherapeuticsMD (TXMD) Misses Q2 EPS by 2c, Revenues Beat
August 6, 2020 6:59 AM EDTTherapeuticsMD (NASDAQ: TXMD) reported Q2 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $10.7 million versus the consensus estimate of $10.38 million.
Our organization made significant progress in the second quarter while navigating the COVID-19 pandemic and... More
